Healthcare AI leader Desheng Biotech (2526.HK) opens subscription today, entry fee HK$5681.73

robot
Abstract generation in progress

Gelonghui March 20 | The world’s only and largest parameter-scale AI medical imaging foundation model pioneer, DeShi Bio (2526.HK), is opening its IPO from today until next Wednesday (March 25). It will issue 7.9992 million H-shares, with 10% available for Hong Kong public offering and 90% for international placement. The offer price ranges from HKD 95.6 to HKD 112.5 per share, raising up to HKD 900 million. A board lot is 50 shares, with an entry fee of HKD 5,681.73. Shares are expected to list on March 30. Huatai International is the sole sponsor.

The company plans to allocate approximately 49% of the net proceeds to the R&D and commercialization of its core product, AI AutoVision; about 10% to other medical imaging software candidate products and medical devices R&D; around 20% to strengthening the iMedImage foundation model and AI technology, as well as enhancing technology licensing business; approximately 8% to expanding commercialization capabilities and market penetration in China; about 5% to expanding global market operations; and roughly 8% to seeking strategic cooperation and investment opportunities with upstream and downstream participants in the medical value chain.

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin